プロカルシトニンの世界市場レポート2020

• 英文タイトル：Global Procalcitonin (CAS 56645-65-9) Sales Market Report 2020

• レポートコード：MRC2102QY11635 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界のプロカルシトニン市場について種類別（プロカルシトニン抗原、プロカルシトニン抗体）、用途別（医療産業、科学研究、獣医用）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・プロカルシトニン市場の概要 ・世界の主要地域別プロカルシトニン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のプロカルシトニン市場規模2015-2026：種類別（プロカルシトニン抗原、プロカルシトニン抗体） ・世界のプロカルシトニン市場規模2015-2026：用途別（医療産業、科学研究、獣医用） ・プロカルシトニンの米国市場規模2015-2020 ・プロカルシトニンのヨーロッパ市場規模2015-2020 ・プロカルシトニンの中国市場規模2015-2020 ・プロカルシトニンの日本市場規模2015-2020 ・プロカルシトニンの東南アジア市場規模2015-2020 ・プロカルシトニンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・プロカルシトニンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・プロカルシトニンの市場動向・機会・課題 ・調査の結論

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Thermo Fisher was the world’s biggest manufacturer in the Procalcitonin (CAS 56645-65-9) industry, accounted for 13% market share of the global market, followed by Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis.The top 5 companies had a combined market share of 35% of the global total.Europe was the largest consumption and production area in the world in 2018.

Market Analysis and Insights: Global Procalcitonin (CAS 56645-65-9) Market
The global Procalcitonin (CAS 56645-65-9) market size is projected to reach US$ 108.5 million by 2026, from US$ 71 million in 2020, at a CAGR of 7.3% during 2021-2026.

Global Procalcitonin (CAS 56645-65-9) Scope and Market Size
The global Procalcitonin (CAS 56645-65-9) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Procalcitonin (CAS 56645-65-9) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Procalcitonin (CAS 56645-65-9) market is segmented into
Procalcitonin Antigen
Procalcitonin Antibody
The segment of antigen holds a comparatively larger share in global market, which accounts for about 70%.

Segment by Application, the Procalcitonin (CAS 56645-65-9) market is segmented into
Medical Industry
Scientific Research
Veterinarian
The medical industry holds an important share in terms of applications, and accounts for 90% of the market share.

The Procalcitonin (CAS 56645-65-9) market is analysed and market size information is provided by regions (countries). Segment by Application, the Procalcitonin (CAS 56645-65-9) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Procalcitonin (CAS 56645-65-9) Market Share Analysis
Procalcitonin (CAS 56645-65-9) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Procalcitonin (CAS 56645-65-9) business, the date to enter into the Procalcitonin (CAS 56645-65-9) market, Procalcitonin (CAS 56645-65-9) product introduction, recent developments, etc.

The major vendors covered:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis

レポート目次

---

1 Procalcitonin (CAS 56645-65-9) Market Overview
1.1 Procalcitonin (CAS 56645-65-9) Product Scope
1.2 Procalcitonin (CAS 56645-65-9) Segment by Type
1.2.1 Global Procalcitonin (CAS 56645-65-9) Sales by Type (2020-2026)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin (CAS 56645-65-9) Segment by Application
1.3.1 Global Procalcitonin (CAS 56645-65-9) Sales Comparison by Application (2020-2026)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Procalcitonin (CAS 56645-65-9) Sales Growth Rate (2015-2026)
1.4.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Growth Rate (2015-2026)
1.4.3 Global Procalcitonin (CAS 56645-65-9) Price Trends (2015-2026)

2 Procalcitonin (CAS 56645-65-9) Estimate and Forecast by Region
2.1 Global Procalcitonin (CAS 56645-65-9) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Procalcitonin (CAS 56645-65-9) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Region (2015-2020)
2.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Region (2015-2020)
2.3 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Procalcitonin (CAS 56645-65-9) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
2.4.2 Europe Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
2.4.3 China Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
2.4.4 Japan Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
2.4.6 India Procalcitonin (CAS 56645-65-9) Estimates and Projections (2015-2026)
3 Global Procalcitonin (CAS 56645-65-9) Competition Landscape by Players
3.1 Global Top Procalcitonin (CAS 56645-65-9) Players by Sales (2015-2020)
3.2 Global Top Procalcitonin (CAS 56645-65-9) Players by Revenue (2015-2020)
3.3 Global Procalcitonin (CAS 56645-65-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Procalcitonin (CAS 56645-65-9) as of 2019)
3.4 Global Procalcitonin (CAS 56645-65-9) Average Price by Company (2015-2020)
3.5 Manufacturers Procalcitonin (CAS 56645-65-9) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Procalcitonin (CAS 56645-65-9) Players (Opinion Leaders)
4 Global Procalcitonin (CAS 56645-65-9) Market Size by Type
4.1 Global Procalcitonin (CAS 56645-65-9) Historic Market Review by Type (2015-2020)
4.1.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
4.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Type (2015-2020)
4.1.3 Global Procalcitonin (CAS 56645-65-9) Price by Type (2015-2020)
4.2 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Type (2021-2026)
4.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Type (2021-2026)
4.2.3 Global Procalcitonin (CAS 56645-65-9) Price Forecast by Type (2021-2026)
5 Global Procalcitonin (CAS 56645-65-9) Market Size by Application
5.1 Global Procalcitonin (CAS 56645-65-9) Historic Market Review by Application (2015-2020)
5.1.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
5.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Application (2015-2020)
5.1.3 Global Procalcitonin (CAS 56645-65-9) Price by Application (2015-2020)
5.2 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Application (2021-2026)
5.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Application (2021-2026)
5.2.3 Global Procalcitonin (CAS 56645-65-9) Price Forecast by Application (2021-2026)

6 United States Procalcitonin (CAS 56645-65-9) Market Facts & Figures
6.1 United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
6.2 United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
6.3 United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

7 Europe Procalcitonin (CAS 56645-65-9) Market Facts & Figures
7.1 Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
7.2 Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
7.3 Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

8 China Procalcitonin (CAS 56645-65-9) Market Facts & Figures
8.1 China Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
8.2 China Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
8.3 China Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

9 Japan Procalcitonin (CAS 56645-65-9) Market Facts & Figures
9.1 Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (3015-3030)
9.2 Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
9.3 Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

10 Southeast Asia Procalcitonin (CAS 56645-65-9) Market Facts & Figures
10.1 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

11 India Procalcitonin (CAS 56645-65-9) Market Facts & Figures
11.1 India Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
11.2 India Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
11.3 India Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Procalcitonin (CAS 56645-65-9) Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Procalcitonin (CAS 56645-65-9) Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Corporation Information
12.2.2 Roche Diagnostics Business Overview
12.2.3 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Products Offered
12.2.5 Roche Diagnostics Recent Development
12.3 bioMerieux
12.3.1 bioMerieux Corporation Information
12.3.2 bioMerieux Business Overview
12.3.3 bioMerieux Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 bioMerieux Procalcitonin (CAS 56645-65-9) Products Offered
12.3.5 bioMerieux Recent Development
12.4 HyTest
12.4.1 HyTest Corporation Information
12.4.2 HyTest Business Overview
12.4.3 HyTest Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 HyTest Procalcitonin (CAS 56645-65-9) Products Offered
12.4.5 HyTest Recent Development
12.5 BBI Solutions
12.5.1 BBI Solutions Corporation Information
12.5.2 BBI Solutions Business Overview
12.5.3 BBI Solutions Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BBI Solutions Procalcitonin (CAS 56645-65-9) Products Offered
12.5.5 BBI Solutions Recent Development
12.6 ProSpec
12.6.1 ProSpec Corporation Information
12.6.2 ProSpec Business Overview
12.6.3 ProSpec Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 ProSpec Procalcitonin (CAS 56645-65-9) Products Offered
12.6.5 ProSpec Recent Development
12.7 Wondfo
12.7.1 Wondfo Corporation Information
12.7.2 Wondfo Business Overview
12.7.3 Wondfo Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Wondfo Procalcitonin (CAS 56645-65-9) Products Offered
12.7.5 Wondfo Recent Development
12.8 Ningbo Medicalsystem Biotechnology
12.8.1 Ningbo Medicalsystem Biotechnology Corporation Information
12.8.2 Ningbo Medicalsystem Biotechnology Business Overview
12.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Products Offered
12.8.5 Ningbo Medicalsystem Biotechnology Recent Development
12.9 Wuhan Easy Diagnosis Biomedicine
12.9.1 Wuhan Easy Diagnosis Biomedicine Corporation Information
12.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
12.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Products Offered
12.9.5 Wuhan Easy Diagnosis Biomedicine Recent Development
12.10 Snibe
12.10.1 Snibe Corporation Information
12.10.2 Snibe Business Overview
12.10.3 Snibe Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Snibe Procalcitonin (CAS 56645-65-9) Products Offered
12.10.5 Snibe Recent Development
12.11 Vazyme Biotech
12.11.1 Vazyme Biotech Corporation Information
12.11.2 Vazyme Biotech Business Overview
12.11.3 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.11.5 Vazyme Biotech Recent Development
12.12 Getein Biotech
12.12.1 Getein Biotech Corporation Information
12.12.2 Getein Biotech Business Overview
12.12.3 Getein Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Getein Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.12.5 Getein Biotech Recent Development
12.13 Hotgen Biotech
12.13.1 Hotgen Biotech Corporation Information
12.13.2 Hotgen Biotech Business Overview
12.13.3 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.13.5 Hotgen Biotech Recent Development
12.14 Lumigenex
12.14.1 Lumigenex Corporation Information
12.14.2 Lumigenex Business Overview
12.14.3 Lumigenex Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lumigenex Procalcitonin (CAS 56645-65-9) Products Offered
12.14.5 Lumigenex Recent Development
12.15 Nanjing Norman Biological Technology
12.15.1 Nanjing Norman Biological Technology Corporation Information
12.15.2 Nanjing Norman Biological Technology Business Overview
12.15.3 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Products Offered
12.15.5 Nanjing Norman Biological Technology Recent Development
12.16 Kitgen
12.16.1 Kitgen Corporation Information
12.16.2 Kitgen Business Overview
12.16.3 Kitgen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kitgen Procalcitonin (CAS 56645-65-9) Products Offered
12.16.5 Kitgen Recent Development
12.17 Beijing KeyGen
12.17.1 Beijing KeyGen Corporation Information
12.17.2 Beijing KeyGen Business Overview
12.17.3 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Products Offered
12.17.5 Beijing KeyGen Recent Development
12.18 Beijing Apis
12.18.1 Beijing Apis Corporation Information
12.18.2 Beijing Apis Business Overview
12.18.3 Beijing Apis Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Beijing Apis Procalcitonin (CAS 56645-65-9) Products Offered
12.18.5 Beijing Apis Recent Development

13 Procalcitonin (CAS 56645-65-9) Manufacturing Cost Analysis
13.1 Procalcitonin (CAS 56645-65-9) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Procalcitonin (CAS 56645-65-9)
13.4 Procalcitonin (CAS 56645-65-9) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Procalcitonin (CAS 56645-65-9) Distributors List
14.3 Procalcitonin (CAS 56645-65-9) Customers

15 Market Dynamics
15.1 Procalcitonin (CAS 56645-65-9) Market Trends
15.2 Procalcitonin (CAS 56645-65-9) Opportunities and Drivers
15.3 Procalcitonin (CAS 56645-65-9) Market Challenges
15.4 Procalcitonin (CAS 56645-65-9) Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Procalcitonin (CAS 56645-65-9) Sales (mg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Procalcitonin (CAS 56645-65-9) Sales (mg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Procalcitonin (CAS 56645-65-9) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Procalcitonin (CAS 56645-65-9) Sales (mg) by Region (2015-2020)
Table 5. Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Region (2015-2020)
Table 6. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Region (2015-2020)
Table 8. Global Procalcitonin (CAS 56645-65-9) Sales (mg) Forecast by Region (2021-2026)
Table 9. Global Procalcitonin (CAS 56645-65-9) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Procalcitonin (CAS 56645-65-9) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Procalcitonin (CAS 56645-65-9) (mg) of Key Companies (2015-2020)
Table 13. Global Procalcitonin (CAS 56645-65-9) Sales Share by Company (2015-2020)
Table 14. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Company (2015-2020)
Table 16. Global Procalcitonin (CAS 56645-65-9) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Procalcitonin (CAS 56645-65-9) as of 2019)
Table 17. Global Procalcitonin (CAS 56645-65-9) Average Price (USD/mg) of Key Company (2015-2020)
Table 18. Manufacturers Procalcitonin (CAS 56645-65-9) Manufacturing Sites and Area Served
Table 19. Manufacturers Procalcitonin (CAS 56645-65-9) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Procalcitonin (CAS 56645-65-9) Players
Table 22. Global Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 23. Global Procalcitonin (CAS 56645-65-9) Sales Share by Type (2015-2020)
Table 24. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Procalcitonin (CAS 56645-65-9) Price (mg) by Type (2015-2020)
Table 26. Global Procalcitonin (CAS 56645-65-9) Sales Share by Type (2021-2026)
Table 27. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Type (2021-2026)
Table 29. Global Procalcitonin (CAS 56645-65-9) Price (mg) by Type (2021-2026)
Table 30. Global Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 31. Global Procalcitonin (CAS 56645-65-9) Sales Share by Application (2015-2020)
Table 32. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Procalcitonin (CAS 56645-65-9) Price (mg) by Application (2015-2020)
Table 34. Global Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2021-2026)
Table 35. Global Procalcitonin (CAS 56645-65-9) Sales Share by Application (2021-2026)
Table 36. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Application (2021-2026)
Table 38. Global Procalcitonin (CAS 56645-65-9) Price (mg) by Application (2021-2026)
Table 39. United States Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 40. United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 41. United States Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 42. United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 43. United States Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 44. United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
Table 45. Europe Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 46. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 47. Europe Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 48. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 49. Europe Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 50. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 51. China Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 52. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 53. China Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 54. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 55. China Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 56. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
Table 57. Japan Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 58. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 59. Japan Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 60. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 61. Japan Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 62. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 64. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 66. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 68. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
Table 69. India Procalcitonin (CAS 56645-65-9) Sales (mg) by Company (2015-2020)
Table 70. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Company (2015-2020)
Table 71. India Procalcitonin (CAS 56645-65-9) Sales (mg) by Type (2015-2020)
Table 72. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2015-2020)
Table 73. India Procalcitonin (CAS 56645-65-9) Sales (mg) by Application (2015-2020)
Table 74. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Corporation Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Procalcitonin (CAS 56645-65-9) Product
Table 79. Thermo Fisher Recent Development
Table 80. Roche Diagnostics Corporation Information
Table 81. Roche Diagnostics Description and Business Overview
Table 82. Roche Diagnostics Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Roche Diagnostics Procalcitonin (CAS 56645-65-9) Product
Table 84. Roche Diagnostics Recent Development
Table 85. bioMerieux Corporation Information
Table 86. bioMerieux Description and Business Overview
Table 87. bioMerieux Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. bioMerieux Procalcitonin (CAS 56645-65-9) Product
Table 89. bioMerieux Recent Development
Table 90. HyTest Corporation Information
Table 91. HyTest Description and Business Overview
Table 92. HyTest Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. HyTest Procalcitonin (CAS 56645-65-9) Product
Table 94. HyTest Recent Development
Table 95. BBI Solutions Corporation Information
Table 96. BBI Solutions Description and Business Overview
Table 97. BBI Solutions Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. BBI Solutions Procalcitonin (CAS 56645-65-9) Product
Table 99. BBI Solutions Recent Development
Table 100. ProSpec Corporation Information
Table 101. ProSpec Description and Business Overview
Table 102. ProSpec Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. ProSpec Procalcitonin (CAS 56645-65-9) Product
Table 104. ProSpec Recent Development
Table 105. Wondfo Corporation Information
Table 106. Wondfo Description and Business Overview
Table 107. Wondfo Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. Wondfo Procalcitonin (CAS 56645-65-9) Product
Table 109. Wondfo Recent Development
Table 110. Ningbo Medicalsystem Biotechnology Corporation Information
Table 111. Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 112. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 113. Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Product
Table 114. Ningbo Medicalsystem Biotechnology Recent Development
Table 115. Wuhan Easy Diagnosis Biomedicine Corporation Information
Table 116. Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 117. Wuhan Easy Diagnosis Biomedicine Description and Business Overview
Table 118. Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Product
Table 119. Wuhan Easy Diagnosis Biomedicine Recent Development
Table 120. Snibe Corporation Information
Table 121. Snibe Description and Business Overview
Table 122. Snibe Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 123. Snibe Procalcitonin (CAS 56645-65-9) Product
Table 124. Snibe Recent Development
Table 125. Vazyme Biotech Corporation Information
Table 126. Vazyme Biotech Description and Business Overview
Table 127. Vazyme Biotech Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 128. Vazyme Biotech Procalcitonin (CAS 56645-65-9) Product
Table 129. Vazyme Biotech Recent Development
Table 130. Getein Biotech Corporation Information
Table 131. Getein Biotech Description and Business Overview
Table 132. Getein Biotech Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 133. Getein Biotech Procalcitonin (CAS 56645-65-9) Product
Table 134. Getein Biotech Recent Development
Table 135. Hotgen Biotech Corporation Information
Table 136. Hotgen Biotech Description and Business Overview
Table 137. Hotgen Biotech Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 138. Hotgen Biotech Procalcitonin (CAS 56645-65-9) Product
Table 139. Hotgen Biotech Recent Development
Table 140. Lumigenex Corporation Information
Table 141. Lumigenex Description and Business Overview
Table 142. Lumigenex Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 143. Lumigenex Procalcitonin (CAS 56645-65-9) Product
Table 144. Lumigenex Recent Development
Table 145. Nanjing Norman Biological Technology Corporation Information
Table 146. Nanjing Norman Biological Technology Description and Business Overview
Table 147. Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 148. Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Product
Table 149. Nanjing Norman Biological Technology Recent Development
Table 150. Kitgen Corporation Information
Table 151. Kitgen Description and Business Overview
Table 152. Kitgen Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 153. Kitgen Procalcitonin (CAS 56645-65-9) Product
Table 154. Kitgen Recent Development
Table 155. Beijing KeyGen Corporation Information
Table 156. Beijing KeyGen Description and Business Overview
Table 157. Beijing KeyGen Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 158. Beijing KeyGen Procalcitonin (CAS 56645-65-9) Product
Table 159. Beijing KeyGen Recent Development
Table 160. Beijing Apis Corporation Information
Table 161. Beijing Apis Description and Business Overview
Table 162. Beijing Apis Procalcitonin (CAS 56645-65-9) Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 163. Beijing Apis Procalcitonin (CAS 56645-65-9) Product
Table 164. Beijing Apis Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Procalcitonin (CAS 56645-65-9) Distributors List
Table 168. Procalcitonin (CAS 56645-65-9) Customers List
Table 169. Procalcitonin (CAS 56645-65-9) Market Key Trends
Table 170. Procalcitonin (CAS 56645-65-9) Key Opportunities and Drivers
Table 171. Procalcitonin (CAS 56645-65-9) Market Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Procalcitonin (CAS 56645-65-9) Product Picture
Figure 2. Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Procalcitonin (CAS 56645-65-9) Market Share by Application in 2020 & 2026
Figure 6. Medical Industry Examples
Figure 7. Scientific Research Examples
Figure 8. Veterinarian Examples
Figure 9. Global Procalcitonin (CAS 56645-65-9) Sales (mg) Growth Rate (2015-2026)
Figure 10. Global Procalcitonin (CAS 56645-65-9) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Procalcitonin (CAS 56645-65-9) Price Trends Growth Rate (2015-2026) (USD/mg)
Figure 12. Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Procalcitonin (CAS 56645-65-9) Sales (mg) Growth Rate (2015-2026)
Figure 16. Europe Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Procalcitonin (CAS 56645-65-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Procalcitonin (CAS 56645-65-9) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Procalcitonin (CAS 56645-65-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Procalcitonin (CAS 56645-65-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Procalcitonin (CAS 56645-65-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Procalcitonin (CAS 56645-65-9) Players Market Share by Revenue in Procalcitonin (CAS 56645-65-9) 2015 & 2019
Figure 27. Procalcitonin (CAS 56645-65-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Type (2015-2020)
Figure 29. Global Procalcitonin (CAS 56645-65-9) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Procalcitonin (CAS 56645-65-9) Revenue Share by Application (2015-2020)
Figure 31. Global Procalcitonin (CAS 56645-65-9) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 33. United States Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 34. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Company in 2019
Figure 35. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 36. Europe Procalcitonin (CAS 56645-65-9) Sales Market Share by Application in 2019
Figure 37. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Company in 2019
Figure 38. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 39. China Procalcitonin (CAS 56645-65-9) Sales Market Share by Application in 2019
Figure 40. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Company in 2019
Figure 41. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 42. Japan Procalcitonin (CAS 56645-65-9) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Market Share by Application in 2019
Figure 46. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Company in 2019
Figure 47. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Type in 2019
Figure 48. India Procalcitonin (CAS 56645-65-9) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Procalcitonin (CAS 56645-65-9)
Figure 51. Manufacturing Process Analysis of Procalcitonin (CAS 56645-65-9)
Figure 52. Procalcitonin (CAS 56645-65-9) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

---